Design Therapeutics, Inc. (DSGN)
15.55
+1.33
(+9.35%)
USD |
NASDAQ |
May 11, 16:00
15.55
0.00 (0.00%)
After-Hours: 19:56
Design Therapeutics EPS Diluted (Quarterly) : -0.2871 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| vTv Therapeutics, Inc. | -0.5752 |
| Immuneering Corp. | -0.1793 |
| X4 Pharmaceuticals, Inc. | -0.1603 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.64M |
| Total Expenses (Quarterly) | 17.64M |
| Enterprise Value | 668.05M |
| Earnings Yield | -7.68% |
| Normalized Earnings Yield | -7.675 |